A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
Clinical trial NCT04707196 · COMPLETED
Trial details
- NCT number
- NCT04707196
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2023-01-09
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.